Vector's BIO Annual Review 2025 uncovers how leading CDMOs, CROs, and biopharma companies are tackling:

‍

• ‍AI disruption across every function
• ‍The Cell & Gene Therapy talent crunch
• Emerging global talent hubs like Abu Dhabi
• Inclusion and storytelling as business drivers
• Building resilient public–private workforce ecosystems

‍

If you’re a business leader or HR/TA executive in life sciences, this is your blueprint for aligning talent with business priorities.

‍

What Leaders Are Saying

“We hire for relationships. Patients choose trials based on trust—and that trust starts with people.” — Mary Gunn, CEO, Emerald Clinical

‍

“It’s not just about capacity. It’s about aligning talent, infrastructure, and partnerships to move at the speed of science.” — Tom Wilson, CCO, AmbioPharma